Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
9670 studies found for:    "Gastrointestinal Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System
Condition: Gastrointestinal Neoplasms
Interventions: Device: ultrasonic microbubbles;   Drug: platinum and gemcitabine
2 Recruiting Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery
Condition: Gastrointestinal Neoplasms
Interventions: Procedure: Laparoscopic Surgery;   Device: Acupuncture treatment
3 Completed Study of Minnelide™ in Patients With Advanced GI Tumors
Condition: Advanced Gastrointestinal Tumors
Intervention: Drug: Minnelide™ 001
4 Completed Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Condition: Upper Gastrointestinal Tumours
Intervention: Drug: Irinotecan, Capecitabine
5 Active, not recruiting Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
Condition: Malignant Digestive System Neoplasm
Interventions: Drug: Alisertib;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin
6 Completed A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
Condition: Upper Gastrointestinal Tumours
Intervention: Drug: Irinotecan, 5-Fluorouracil, Leucovorin
7 Active, not recruiting A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.
Condition: Advanced Gastrointestinal Tumors
Interventions: Drug: TAS-102;   Drug: CPT-11;   Drug: Bevacizumab
8 Unknown  Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro
Condition: Gastrointestinal Neoplasms
9 Completed S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Condition: Gastrointestinal Neoplasms
Intervention: Drug: OIS (Oxaliplatin, Irinotecan, S-1)
10 Completed Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors
Conditions: Metastatic Breast Cancer;   Gastrointestinal Tumors
Interventions: Drug: Sorafenib;   Drug: Capecitabine
11 Recruiting Cerebral Blood Flow During Propofol Anaesthesia
Condition: Gastrointestinal Neoplasms
Intervention: Other: Study of cerebral blood flow
12 Not yet recruiting Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma
Condition: Gastrointestinal Neoplasms
Interventions: Drug: Cinobufacini injection;   Drug: chemotherapy
13 Recruiting Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers
Condition: Gastrointestinal Neoplasms
Interventions: Drug: Ganoderma Spore Lipids;   Drug: Placebo;   Drug: Chemotherapy
14 Active, not recruiting EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract
Condition: Gastrointestinal Neoplasms
Interventions: Device: EUS-FNA;   Device: EUS-Endodrill biopsy
15 Recruiting Improvement of Colonoscopy Preparation by New Media (APP)
Condition: Gastrointestinal Neoplasms
Intervention: Device: APP supported colonoscopy preparation
16 Active, not recruiting Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients
Condition: Gastrointestinal Neoplasms
Intervention: Behavioral: Education/Daily Planning
17 Recruiting Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Condition: Gastrointestinal Neoplasms
Interventions: Drug: LGG;   Drug: Placebo
18 Active, not recruiting Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET
Condition: Gastrointestinal Neoplasms
Interventions: Drug: Everolimus;   Drug: octreotide LAR
19 Unknown  Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation
Condition: Gastrointestinal Neoplasms
20 Terminated Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies
Condition: Gastrointestinal Neoplasms
Intervention: Drug: BMS-582664

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.